Show simple item record

dc.contributor.authorBiCARB Study Group
dc.date.accessioned2020-04-09T10:20:01Z
dc.date.available2020-04-09T10:20:01Z
dc.date.issued2020-04-09
dc.identifier.citationBiCARB Study Group 2020 , ' Clinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB) : a pragmatic randomised, double-blind, placebo-controlled trial ' , BMC medicine , vol. 18 , 91 . https://doi.org/10.1186/s12916-020-01542-9en
dc.identifier.issn1741-7015
dc.identifier.otherPURE: 158293942
dc.identifier.otherPURE UUID: b071a69c-98b9-4c87-9add-0fee5d8a0953
dc.identifier.otherScopus: 85083272904
dc.identifier.otherWOS: 000525712000001
dc.identifier.otherORCID: /0000-0002-1397-4272/work/76609009
dc.identifier.urihttps://hdl.handle.net/2164/14002
dc.descriptionWe acknowledge the support received via the NHS Scotland Support for Science scheme; the NIHR Renal and Ageing Comprehensive Research Networks; and the work of all of the research nurses, local investigators and study teams at sites; Tayside Clinical Trials Unit staff; and most importantly all those with kidney disease who participated in the trial. Professor Witham acknowledges support from the NIHR Newcastle Biomedical Research Centre. In addition, we acknowledge the support and advice we received from the independent Trial Steering Committee members (Professor David Stott, Professor Patrick Mark, Professor Tahir Masud and Mr. Alex Stephen) and the independent Data Monitoring Committee (Professor Alex McConnachie, Professor David Wheeler, Dr. Nicosha de Souza, Professor Andrew Clegg). We also acknowledge the efforts of all the investigators, site research nurses and support teams. Funding The BiCARB trial was funded by the National Institute for Health Research Health Technology Assessment programme (project reference 10/71/01). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. The funder of the study had input into the study design via the original commissioning call specification. The funder had no other role in the study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit. Disclaimer: The Health Services Research Unit and Health Economics Research Unit are core funded by the Chief Scientist Office of the Scottish Government Health and Social Care Directorate.en
dc.format.extent16
dc.language.isoeng
dc.relation.ispartofBMC medicineen
dc.rights© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectsodium bicarbonateen
dc.subjectrenal insufficiencyen
dc.subjectchronicen
dc.subjectAcidosisen
dc.subjectrandomised controlled trialen
dc.subjectR Medicineen
dc.subjectMedicine(all)en
dc.subjectNational Institute for Health Research (NIHR)en
dc.subject10/71/01en
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titleClinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB) : a pragmatic randomised, double-blind, placebo-controlled trialen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Health Economics Research Uniten
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Health Services Research Uniten
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Public Health, Health Services and Primary Careen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1186/s12916-020-01542-9
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85083272904&partnerID=8YFLogxKen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record